Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Fredrik Thunarf"'
Autor:
Pierfrancesco Tassone, Maria Teresa Di Martino, Mariamena Arbitrio, Lucia Fiorillo, Nicoletta Staropoli, Domenico Ciliberto, Alessia Cordua, Francesca Scionti, Bernardo Bertucci, Angela Salvino, Mariangela Lopreiato, Fredrik Thunarf, Onofrio Cuomo, Maria Cristina Zito, Maria Rosanna De Fina, Amelia Brescia, Simona Gualtieri, Caterina Riillo, Francesco Manti, Daniele Caracciolo, Vito Barbieri, Eugenio Donato Di Paola, Adele Emanuela Di Francesco, Pierosandro Tagliaferri
Publikováno v:
Journal of Hematology & Oncology, Vol 16, Iss 1, Pp 1-12 (2023)
Abstract Background We developed a 13-mer locked nucleic acid (LNA) inhibitor of miR-221 (LNA-i-miR-221) with a full phosphorothioate (PS)-modified backbone. This agent downregulated miR-221, demonstrated anti-tumor activity against human xenografts
Externí odkaz:
https://doaj.org/article/4d9a753abc2e49c2bbde30064f04d177
Autor:
Lisa Zarantonello, Hannes Hagström, Bruce F. Scharschmidt, Irina Kozlova, Lars-Erik Lins, Joe Mauney, Igor A. Zupanets, Maja Johansson, Martin Schalling, Krzysztof Tomasiewicz, Sara Montagnese, Torbjörn Bäckström, Elena Bunkova, Sergey Fitilev, Fredrik Thunarf, Masoud Mokhatarani, Dag Nilsson, Mette Munk Lauridsen, Maria Månsson, Fredrik Rorsman, Hendrik Vilstrup, Jan Erik Berglund, Stergios Kechagias, Eva Arlander, Carin Edmark Ocklind, Per Samuelson, Magnus Doverskog, Geza Lakner
Publikováno v:
Montagnese, S, Lauridsen, M, Vilstrup, H, Zarantonello, L, Lakner, G, Fitilev, S, Zupanets, I, Kozlova, I, Bunkova, E, Tomasiewicz, K, Berglund, J E, Rorsman, F, Hagström, H, Kechagias, S, Ocklind, C E, Mauney, J, Thunarf, F, Mokhatarani, M, Bäckström, T, Doverskog, M, Lins, L-E, Månsson, M, Samuelson, P, Nilsson, D, Schalling, M, Johansson, M, Arlander, E & Scharschmidt, B F 2021, ' A pilot study of Golexanolone, a new GABA-A receptor modulating steroid antagonist, in patients with covert hepatic encephalopathy ', Journal of Hepatology, vol. 75, no. 1, pp. 98-107 . https://doi.org/10.1016/j.jhep.2021.03.012
Montagnese, S, Lauridsen, M, Vilstrup, H, Zarantonello, L, Lakner, G, Fitilev, S, Zupanets, I, Kozlova, I, Bunkova, E, Tomasiewicz, K, Berglund, J E, Rorsman, F, Hagström, H, Kechagias, S, Ocklind, C E, Mauney, J, Thunarf, F, Mokhatarani, M, Bäckström, T, Doverskog, M, Lins, L E, Månsson, M, Samuelson, P, Nilsson, D, Schalling, M, Johansson, M, Arlander, E & Scharschmidt, B F 2021, ' A pilot study of golexanolone, a new GABA-A receptor-modulating steroid antagonist, in patients with covert hepatic encephalopathy ', Journal of Hepatology, vol. 75, no. 1, pp. 98-107 . https://doi.org/10.1016/j.jhep.2021.03.012
Montagnese, S, Lauridsen, M, Vilstrup, H, Zarantonello, L, Lakner, G, Fitilev, S, Zupanets, I, Kozlova, I, Bunkova, E, Tomasiewicz, K, Berglund, J E, Rorsman, F, Hagström, H, Kechagias, S, Ocklind, C E, Mauney, J, Thunarf, F, Mokhatarani, M, Bäckström, T, Doverskog, M, Lins, L E, Månsson, M, Samuelson, P, Nilsson, D, Schalling, M, Johansson, M, Arlander, E & Scharschmidt, B F 2021, ' A pilot study of golexanolone, a new GABA-A receptor-modulating steroid antagonist, in patients with covert hepatic encephalopathy ', Journal of Hepatology, vol. 75, no. 1, pp. 98-107 . https://doi.org/10.1016/j.jhep.2021.03.012
Background & Aims: Golexanolone is a novel small molecule GABA-A receptor-modulating steroid antagonist under development for the treatment of cognitive and vigilance disorders caused by allosteric over-activation of GABA-A receptors by neurosteroids
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::613812756658061eab0ae50a1ba374dd
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-449351
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-449351
Autor:
Mikołaj Krzyżanowski, Krystyna Twardowska-Saucha, Grzegorz Dziwiszek, Arkadiusz Jawień, Michal Dyaczynski, Andrzej Nykaza, Folke Sjöberg, Jakob Björk, Jakub Orleanski, Adam Sidorowicz, Jacek Mikosiński, Marek Karczewski, Adam Wegrzynowski, Tomasz Grzela, Beata Belz-Lagoda, Margit Mahlapuu, Fredrik Thunarf, Monika Kujawiak, Jan Apelqvist, Jonas Ekblom
Many patients with venous leg ulcers do not reach complete healing with compression treatment alone, which is current standard care. This clinical trial HEAL LL-37 was a phase IIb double-blind, randomized, placebo-controlled study, with the aim to ev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1d31d702bb12aeffd1ec3334bf8135f
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-180733
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-180733